A new study finds, specifically taking full-strength aspirin was linked to a 26 percent reduction, while low-dose aspirin reduced the risk of pancreatic cancer by 35 percent.
Authors of the study presented at the annual meeting of the American Association for Cancer Research caution the results are not meant to suggest everyone should start taking aspirin. It should be discussed with your doctors since the drug carries some side effects.
